Failure of Researchers, Reviewers, Editors, and the Media to Understand Flaws in Cancer Screening Studies: Application to an Article in CancerBERRY, Donald A.Cancer. 2014, Vol 120, Num 18, pp 2784-2791, issn 0008-543X, 8 p.Article

Optimal adaptive randomized designs for clinical trialsYI CHENG; BERRY, Donald A.Biometrika. 2007, Vol 94, Num 3, pp 673-689, issn 0006-3444, 17 p.Article

Determining joint carrier probabilities of cancer-causing genes using markov chain Monte Carlo methodsBISWAS, Swati; BERRY, Donald A.Genetic epidemiology. 2005, Vol 29, Num 2, pp 141-154, issn 0741-0395, 14 p.Article

Interpreting adjuvant breast cancer data in 2006 and beyondBERRY, Donald A.European journal of cancer. Supplement (1990). 2006, Vol 4, Num 13, pp 17-22, issn 1359-6349, 6 p.Conference Paper

Biomarker studies and other difficult inferential problems : Statistical caveatsBERRY, Donald A.Seminars in oncology. 2007, Vol 34, Num 2, issn 0093-7754, S17-S22, SUP3Conference Paper

Choosing sample size for a clinical trial using decision analysisYI CHENG; FUSHENG SU; BERRY, Donald A et al.Biometrika. 2003, Vol 90, Num 4, pp 923-936, issn 0006-3444, 14 p.Article

Symmetrized percent change for treatment comparisonsBERRY, Donald A; AYERS, Gregory D.The American statistician. 2006, Vol 60, Num 1, pp 27-31, issn 0003-1305, 5 p.Article

The past is the future : Innovative designs in acute stroke therapy trialsKRAMS, Michael; LEES, Kennedy R; BERRY, Donald A et al.Stroke (1970). 2005, Vol 36, Num 6, pp 1341-1347, issn 0039-2499, 7 p.Article

Detecting an Overall Survival Benefit that Is Derived From Progression-Free SurvivalBROGLIO, Kristine R; BERRY, Donald A.Journal of the National Cancer Institute. 2009, Vol 101, Num 23, pp 1642-1649, issn 0027-8874, 8 p.Article

Reports from the 2010 Clinical and Translational Cancer Research Think Tank Meeting: Design Strategies for Personalized Therapy TrialsBERRY, Donald A; HERBST, Roy S; RUBIN, Eric H et al.Clinical cancer research (Print). 2012, Vol 18, Num 3, pp 638-644, issn 1078-0432, 7 p.Article

Relationship between Bayesian and frequentist sample size determinationINOUE, Lurdes Y. T; BERRY, Donald A; PARMIGIANI, Giovanni et al.The American statistician. 2005, Vol 59, Num 1, pp 79-87, issn 0003-1305, 9 p.Article

Body Mass Index and Breast Cancer Risk According to Postmenopausal Estrogen-Progestin Use and Hormone Receptor StatusMUNSELL, Mark F; SPRAGUE, Brian L; BERRY, Donald A et al.Epidemiologic reviews. 2014, Vol 36, pp 114-136, issn 0193-936X, 23 p.Article

Chemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)ESSERMAN, Laura J; BERRY, Donald A; BUXTON, Meredith B et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 1049-1062, issn 0167-6806, 14 p.Article

Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation: A Randomized Controlled TrialWILBER, David J; PAPPONE, Carlo; REDDY, Vivek et al.JAMA, the journal of the American Medical Association. 2010, Vol 303, Num 4, pp 333-340, issn 0098-7484, 8 p.Article

Influence of Activation State of ErbB-2 (HER-2) on Response to Adjuvant Cyclophosphamide, Doxorubicin, and Fluorouracil for Stage II, Node-Positive Breast Cancer : Study 8541 From the Cancer and Leukemia Group BDIGIOVANNA, Michael P; STERN, David F; BERRY, Donald A et al.Journal of clinical oncology. 2008, Vol 26, Num 14, pp 2364-2372, issn 0732-183X, 9 p.Article

Nomograms to predict pathologic complete response and metastasis-free survival after preoperative chemotherapy for breast cancerROUZIER, Roman; PUSZTAI, Lajos; SYMMANS, W. Fraser et al.Journal of clinical oncology. 2005, Vol 23, Num 33, pp 8331-8339, issn 0732-183X, 9 p.Article

Monitoring a clinical trial conducted under the Food and Drug Administration regulations allowing a waiver of prospective informed consent : The diaspirin cross-linked hemoglobin traumatic hemorrhagic shock efficacy trialLEWIS, Roger J; BERRY, Donald A; FISHER, Marian et al.Annals of emergency medicine. 2001, Vol 38, Num 4, pp 397-404, issn 0196-0644Article

Outcomes of Phase II Clinical Trials with Single-Agent Therapies in Advanced/Metastatic Non―Small Cell Lung Cancer Published between 2000 and 2009JANKU, Filip; BERRY, Donald A; JING GONG et al.Clinical cancer research (Print). 2012, Vol 18, Num 22, pp 6356-6363, issn 1078-0432, 8 p.Article

p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905)LARA, Jonathan F; THOR, Ann D; CRAIG HENDERSON, I et al.Clinical cancer research (Print). 2011, Vol 17, Num 15, pp 5170-5178, issn 1078-0432, 9 p.Article

Primary hyperparathyroidism and osteosarcoma : Examination of a large cohort identifies three cases of fibroblastic osteosarcomaJIMENEZ, Camilo; YING YANG; KIM, Hyung-Woo et al.Journal of bone and mineral research (Print). 2005, Vol 20, Num 9, pp 1562-1568, issn 0884-0431, 7 p.Article

Additive benefits of pravastatin and aspirin to decrease risks of cardiovascular disease: Randomized and observational comparisons of secondary prevention trials and their meta-analysesHENNEKENS, Charles H; SACKS, Frank M; NATARAJAN, Kannan et al.Archives of internal medicine (1960). 2004, Vol 164, Num 1, pp 40-44, issn 0003-9926, 5 p.Article

Adaptive randomized study of idarubicin and cytarabine versus Troxacitabine and cytarabine versus Troxacitabine and idarubicin in untreated Patients 50 years or older with adverse karyotype acute myeloid leukemiaGILES, Francis J; KANTARJIAN, Hagop M; XIAO, Lian-Chun et al.Journal of clinical oncology. 2003, Vol 21, Num 9, pp 1722-1727, issn 0732-183X, 6 p.Article

BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genesBERRY, Donald A; IVERSEN, Edwin S; RUBINSTEIN, Wendy S et al.Journal of clinical oncology. 2002, Vol 20, Num 11, pp 2701-2712, issn 0732-183XArticle

Cancer genomics : Promises and complexitiesWEI ZHANG; LABORDE, Pilar M; COOMBES, Kevin R et al.Clinical cancer research. 2001, Vol 7, Num 8, pp 2159-2167, issn 1078-0432Article

Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL: CALGB 150007/150012, ACRIN 6657ESSERMAN, Laura J; BERRY, Donald A; LIVASY, Chad et al.Journal of clinical oncology. 2012, Vol 30, Num 26, pp 3242-3249, issn 0732-183X, 8 p.Article